(Ser⁸)-GLP-1 (7-36) amide (human, bovine, guinea pig, mouse, rat) |
| カタログ番号GA20306 |
アラニンをセリンに置換することで、DPP IVに対するGLP-1（7-36）アミドの血漿安定性が大幅に向上し、インスリントロピック活性は損なわれませんでした。これは、この修飾がGLP-1のタイプII糖尿病治療への可能性を高めることができることを示唆しています。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 215777-46-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
The replacement of alanine by serine significantly improved the plasma stability of GLP-1 (7-36) amide against DPP IV without impairing its insulinotropic activity. This may indicate that this modification could improve the potential of GLP-1 in the tr
Average Rating: 5 (Based on Reviews and 32 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *